சீன சமூகம் ஆஃப் இருதயவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சீன சமூகம் ஆஃப் இருதயவியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சீன சமூகம் ஆஃப் இருதயவியல் Today - Breaking & Trending Today

Chinese Medicine in treatment of diabetic heart disease

Diabetic coronary heart disease (DCHD), the mainly macrovascular complication of type 2 diabetes mellitus (T2DM), is greatly harmful to T2DM patients. ....

United States , Sri Lanka , Eteläuomen Läi , South Korea , Coll Cardiol , Cardiovasc Diabetol , Rao Kondapally Seshasai , Shen Qi Hua Yu , Fufang Zhenzhu Tiaozhi , Nonogakik Dysglycemia , Chinj Cardiol , Statement From The American Heart Association , American Heart Association , Chinese Diabetes Society , First Affiliated Hospital Of Guangdong Pharmaceutical University , Study Group , American Diabetes Association , Development Program Of China , American College Of Cardiology Foundation , National Key Research , Ethics Committee , Guoj Research , Chinese Society Of Cardiology , First Affiliated Hospital , Guangdong Pharmaceutical University , Development Program ,

Amarin (AMRN) Q1 2021 Earnings Call Transcript

Amarin (AMRN) Q1 2021 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
Amarin (NASDAQ: AMRN)
Welcome to Amarin Corporation s conference call to discuss its first-quarter 2021 financial results and operational updates. This conference call is being recorded today, April 29, 2021. I would like to turn the conference call over to Alina Doubrovna, associate manager of investor relations at Amarin.
Alina Doubrovna
Associate Manager of Investor Relations
Thank you, operator, and thank you to everyone for joining our first-quarter 2021 results. Before we begin, let me turn to our forward-looking statements. Please be aware that this conference call will contain forward-looking statements that are intended to be covered under the safe harbor provided by the Private Securities Litigation Reform Act. Examples of such statements include, but are not limited to: our current exp ....

New York , United States , Hong Kong , United Kingdom , New Jersey , Europe Karim Mikhail , Jessica Fye , Aaron Berg , Mike Kalb , Michael Yee , Louise Chen Cantor Fitzgerald , Karim Mikhail , John Thero , Michael Kalb , Joe Kennedy , Alina Doubrovna , Steve Ketchum , Paul Choi Goldman Sachs , Piper Sandler , Louise Chen , Michael Yee Jefferies , Paul Choi , Yasmeen Rahimi , Yasmeen Rahimi Piper Sandler , Egyptian Cardiovascular Society , European Commission ,

Amarin Reports First Quarter 2021 Financial Results and Provides Business Update

Share:
Commercial Launch of VAZKEPA in Europe on Track to Commence in Q3 2021 Following Recent Market Authorization with VASCEPA® Growth in the United States Positioned to Increase as the Impact of COVID-19 Recedes
Expenses Managed in Q1 2021 to Minimize Operating Loss Despite Revenue Impact of COVID-19 and Other Factors
Management to Host Conference Call Today at 7:30 a.m. ET
DUBLIN, Ireland and BRIDGEWATER, N.J., April 29, 2021 (GLOBE NEWSWIRE) Amarin Corporation plc (NASDAQ:AMRN), today announced financial results for the quarter ended March 31, 2021 and provided an update on company operations.
Recent Key Amarin Highlights:
Q1 net total revenue
: Net total revenue in the first quarter of 2021 was $142.2 million, consisting of $140.8 million in net product revenue from the United States, $0.5 million in net product revenue from outside the United States and $0.8 million in licensing and royalty revenue. Net product revenue from the United State ....

United States , Hong Kong , New Jersey , United Kingdom , United Arab Emirates , Northern Ireland , Great Britain , Coll Cardiol , Clin Cardiol , Karim Mikhail , John Thero , Joseph Kennedy , American Heart Association , Exchange Commission Regulation , European Society Of Cardiology , Journal Of The American College Cardiology , Amarin Pharmaceuticals Ireland , European Union , Chinese National Medical Products Administration , Symphony Health , Drug Administration , European Commission , Exchange Commission , Hong Kong Department Of Health , Amarin Corporation , Chinese Society Of Cardiology ,

Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Amarin Corporation plcFebruary 25, 2021 GMT
Record Revenue of $614.1 Million and $167.3 Million for Full Year and Fourth Quarter 2020 Despite COVID-19 Impact
Received Positive CHMP Opinion for VAZKEPA ®
in Europe and Continue to Advance Commercial Launch Plans for Europe
Management to Host Conference Call Today at 7:30 a.m. ET
DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) Amarin Corporation plc (NASDAQ:AMRN), today announced financial results for the quarter and year ended December 31, 2020 and provided an update on company operations. ....

United States , Hong Kong , New Jersey , United Arab Emirates , Coll Cardiol , Clin Cardiol , Johnf Thero , European Commission , Exchange Commission , Exchange Commission Regulation , Hong Kong Department Of Health , Amarin Corporation , Chinese Society Of Cardiology , European Union , Chinese National Medical Products Administration , Journal Of The American College Cardiology , European Medicines Agency , Hikma Pharmaceuticals , Committee For Medicinal Products Human Use , Symphony Health , Record Revenue , Full Year , Fourth Quarter , Advance Commercial Launch Plans , Host Conference Call Today , Key Amarin Achievements ,

Icosapent Ethyl Included in the Chinese Society of Cardiology (CSC) Updated Guidelines for Primary Prevention of Cardiovascular Diseases

News Category Global Banking & Finance Reviews
Icosapent Ethyl Included in the Chinese Society of Cardiology (CSC) Updated Guidelines for Primary Prevention of Cardiovascular Diseases
Icosapent Ethyl Included in the Chinese Society of Cardiology (CSC) Updated Guidelines for Primary Prevention of Cardiovascular Diseases
DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 21, 2021 Amarin Corporation plc (NASDAQ:AMRN) today announced that the Chinese Society of Cardiology (CSC) has included icosapent ethyl in its updated Guidelines for Primary Prevention of Cardiovascular Diseases for 2021 as published in the
Chinese Journal of Cardiovascular Diseases. The guideline authors include “icosapent ethyl 2 grams twice a day (as studied in REDUCE-IT ....

United States , United Arab Emirates , Clin Cardiol , Coll Cardiol , Craigb Granowitz , Amarin Corporation , Investor Relations Amarin Corporation , Exchange Commission , Cardiovascular Branch Of Chinese Medical Association , Journal Of The American College Cardiology , European Society Of Cardiology , Chinese Society Of Cardiology , Alina Kolomeyer Communications Amarin Corporation , European Atherosclerosis Society , Chinese Society , Primary Prevention , Cardiovascular Diseases , Chinese Journal , European Society , China There , United Arab , New England Journal , American College , Clinical Studies , First Occurrence , Cardiovascular Events ,